mary szela  abbott laboratories company  zoominfocom mary szela  abbott laboratories company  zoominfocom mary szela novelion therapeutics inc profile  biography  bloomberg feedback mary szela chief executive officer novelion therapeutics inc career history chief executive officer novelion therapeutics inc present chief executive officer aegerion pharmaceuticals inc  chief executive officer melinta therapeutics  chief executive officer ribx pharmaceuticals inc  senior vpglobal strategic mktg abbott laboratories inc  senior vpus pharmaceuticals abbott laboratories inc  senior vppharmaceutical ops abbott laboratories inc  vppharmaceutical operations abbott laboratories inc  vppharmaceutical products abbott laboratories inc  vphospital products business abbott laboratories inc  show more website wwwnovelioncom corporate information address  great northern way suite  vancouver bc vt t canada phone  fax  web url wwwnovelioncom from the web personal information education university of illinois bachelors degree nursing  university of illinois mba  memberships board memberships novelion therapeutics inc board member present coherus biosciences inc board member present suneva medical inc board member present novo nordisk as board member  aegerion pharmaceuticals inc board member  receptos inc board member  ribx pharmaceuticals inc chairman unknown show more sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data mary t szela executive profile  biography  bloomberg july    pm et biotechnology company overview of novelion therapeutics inc snapshotpeople  overviewboard memberscommittees executive profile mary t szela chief executive officer and director novelion therapeutics incagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriessee board relationshipsas of fiscal year  background ms mary t szela has been the chief executive officer of novelion therapeutics inc since november   ms szel served as the chief executive officer of aegerion pharmaceuticals inc from january   to november   ms szela served as the chief executive officer of melinta therapeutics inc from april   to august  chairperson since january   and also served as its president ms szela served as a senior vice president of global strategic  marketing and services at abbott diabetes care inc since january  ms szela served as a senior vice president of global strategic marketing and services pharmaceutical products group at abbott laboratories since  and also served as its senior vice president of u s pharmaceuticals from  to  she served more than two decades in senior roles at abbott laboratories she served as senior vice president us pharmaceuticals at abbott diabetes care inc she served as senior vice president of pharmaceutical operations of abbotts commercial pharmaceutical business in the united states from august  to  she served as corporate officer at abbott laboratories since  she served as vice president of commercial pharmaceutical operations at abbott laboratories since  where she was responsible for sales and marketing of many of abbotts pharmaceutical brands including humira she served as vice president of pharmaceutical products primary care operations of abbott laboratories from  to  she joined abbott in  and has held several leadership positions at abbott including divisional vice president of hospital products business sector from  to  she served as general manager of anesthesia hospital products since  she worked for the university of illinois hospital she served as the chairperson of ribx pharmaceuticals inc since january   and has been its director since january   she has been a director of novelion therapeutics inc since november   she has been a director of coherus biosciences inc since july  she has been a director at aegerion pharmaceuticals inc since january   she has been director of arisaph pharmaceuticals inc since  she serves as a director of suneva medical inc she served as director of novo nordisk as from march   to may   she served as a director of melinta therapeutics inc since january   she served as a director of receptos inc from july  to august   ms szela earned a bachelors degree in nursing in  and a masters degree in business administration in  from the university of illinoisread full background corporate headquarters  great northern wayvancouver british columbia vt tcanadaphone fax  board members memberships directorsuneva medical incpresentdirectorarisaph pharmaceuticals incpresentdirectorcoherus biosciences incpresentchief executive officer and directornovelion therapeutics inc education bachelors degree university of illinoisurbanachampaignmba university of illinoisurbanachampaign other affiliations abbott laboratoriesnovo nordisk asmelinta therapeutics incuniversity of illinoisurbanachampaignarisaph pharmaceuticals incaegerion pharmaceuticals incsuneva medical increceptos inccoherus biosciences inc annual compensation salarytotal annual compensation stocks options restricted stock awardsall other compensationunexercisable optionstotal number of options total compensation total annual cash compensationtotal short term compensationother long term compensationtotal calculated compensation request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationthere is no competitor compensation data available sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact novelion therapeutics inc please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close mary t szela  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in mary t szela former dir and chief executive officer at novelion therapeutics inc view full profile are you mary t szela claim your profile   sign up for equilar atlas and view mary t szelas full profile with equilar atlas you can identify corporate executives in mary t szelas network and community follow changes in mary t szelas employment and moneyinmotion connect with mary t szela through your network of contacts mary t szelas executive work history past to view mary t szelas complete executive work history sign up now age      mary t szelas biography chief executive officer of novelion therapeutics inc us member of the board of novo nordisk as and the remuneration committee since  management duties member of the boards of coherus biosciences inc novelion therapeutics inc and suneva medical inc all in the us special competences indepth understanding of the clinical regulatory and marketing aspects of the pharmaceutical industry in north america having both operational and strategic experience education mba  from the university of illinois at chicago us and bsc nursing degree  from the university of illinois at chicago us source novo nordisk as on    sign up for equilar atlas and view mary t szelas full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like mary t szela more specifically youll be able to identify corporate executives in mary t szelas network and community follow changes in mary t szelas employment and moneyinmotion connect with mary t szela through your network of conections view full profile   search for over  executive profiles bio example mary t szela popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith carl g annessa evp and coo hornbeck offshore services inc elon r musk ceo and chairman tesla michael c montgomery board member nmi holdings inc × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login ï¿½  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax   microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft mary t szela of coherus biosciences inc board of directors   welcome company news company site premium log in membership home portfolio stocks bonds funds etfs cef markets tools real life finance discuss investing ideas fund analyst picks picks by category fund pick performance picks  pans enewsletter fund spy column fund spy book bond squad fund video reports fundinvestor newsletter etf investing fund family experts fund reports all fund analyst reports fund stewardship reports fund ratings highestrated value highestrated growth highestrated largecap highestrated midcap highestrated smallcap foreign fund standouts star rating performance rating methodology fund performance top month performers top ytd performers top year performers top year performers top year performers fund category returns biggest daily nav changes closedend funds exchangetraded funds quarterly market outlook fund screeners basic screeners fund screener longterm winners solid smallgrowth funds conservative bond funds premium screeners premium fund screener index funds hidden gems lowerrisk foreign funds video center coherus biosciences inc  chrs add to portfolioget email alertsprint this pagepdf reportdata questionquotechartstock analysisperformancekey ratiosfinancialsvaluationinsidersownershipfilingsbondsoverviewexecutive compensationinsider activitykey executivesboard of directorscommittees board of directors  mary t szela mary t szela independent director profile connections biography mary t szela age  has served as a member of our board of directors since july  in january  ms szela was named chief executive officer of aegerion pharmaceuticals inc and served on its board of directors in november  aegerion pharmaceuticals inc merged with qlt inc to form novelion therapeutics inc where ms szela was named chief executive officer and currently serves on its board of directors ms szela served as the chief executive officer of melinta therapeutics inc an antibiotic development company from april  to august  she also served on the board of directors of melinta from january  to august  ms szela has served as a member of the boards of directors of novo nordisk since march  and suneva medical inc since july  she served as a member of the board of directors of receptos inc from june  to july  previously ms szela joined abbott laboratories in  and held several leadership positions including senior vice president of global strategic marketing from january  to may  and senior vice president of us pharma ceuticals from september  to december  prior to abbott ms szela worked for the university of illinois hospital ms szela earned a bs in nursing and an mba from the university of illinois we believe ms szela is qualified to serve on our board of directors because of her extensive management experience and expertise in pharmaceutical company operations board membership company name board member since board committees novo nordisk as  boardnominationremuneration novelion therapeutics inc  board mary t szela is connected to  board memberssee list of all board connections   we value your feedback let us know what you think site directory site map our products corrections help advertising opportunities licensing opportunities glossary rss mobile portfolio affiliate careers international sites australia canada china france germany hong kong italy the netherlands norway spain uk switzerland stocks by name  ticker  star rating  market cap  stock type  sector  industry mutual funds by star rating  investment style  total assets  category  top holdings  top sectors  symbol  ticker  name etfs by star rating  category  total assets  symbol  ticker  name articles by title  date  author  collection  interest  popularity investment categories by topic  sector  key indicators  user interest  market cap  industry premium stocks by name  ticker  star rating  market cap  stock type  sector  industry premium mutual funds by star rating  investment style  total assets  category  top holdings  top sectors  symbol  ticker  name premium etfs by star rating  category  total assets  symbol  ticker  name popular articles by title  date  author  collection  interest  popularity popular investment categories by topic  sector  key indicators  user interest  market cap  industry independent insightful trusted morningstar provides stock market analysis equity mutual fund and etf research ratings and picks portfolio tools and option hedge fund ira k and  plan research our reliable data and analysis can help both experienced enthusiasts and newcomers  copyright morningstar inc all rights reserved please read our terms of useand privacy policydow jones industrial average sp  nasdaq and morningstar index market barometer quotes are realtime russell  quote is  minutes delayed mary szela ceo melinta pharmaceuticals timesjavascript is disabled market profiles login sign up login sign up   edit person mary szela ceo at melinta pharmaceuticals location chicago ma add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop mary szela ceo at melinta pharmaceuticals location chicago ma add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop mary szela works as chief executive officer at melinta therapeutics she serves as its president and served as its chairperson since january  ms szela has been senior vice president of global strategic marketing and services at abbott diabetes care inc since january  ms szela served as a senior vice president of global strategic marketing and services pharmaceutical products group at abbott laboratories since  and also served as its senior vice president of u s pharmaceuticals from  to  ms szela served more than two decades in senior roles at abbott laboratories ms szela served as senior vice president us pharmaceuticals at abbott diabetes care inc she served as senior vice president of pharmaceutical operations of abbott’s commercial pharmaceutical business in the united states from august  to  she served as corporate officer at abbott laboratories since  she served as vice president of commercial pharmaceutical operations at abbott laboratories since  where she was responsible for sales and marketing of many of abbott’s pharmaceutical brands including humira ms szela served as vice president of pharmaceutical products primary care operations of abbott laboratories from  to  ms szela joined abbott in  and has held several leadership positions at abbott including divisional vice president of hospital products business sector from  to  she served as general manager of anesthesia hospital products since  ms szela worked for the university of illinois hospital she served as the chairperson of ribx pharmaceuticals inc since january  and has been its director since january  she has been a director of coherus biosciences inc since july  and novo nordisk as since march   she has been a director of arisaph pharmaceuticals inc since  and receptos inc since july  she has been a director of melinta therapeutics inc since january  she serves as a director of suneva medical inc  companies in career na related markets na colleagues na related investments alias na industry pharmaceuticals tags pharmaceutical industry sales effectiveness product launch pharmaceutical sales topics of influence web site blog careers achievements investments related people edit view all mary szelacareer  sep coherus biosciences board member may receptos board member jan melinta pharmaceuticals ceo competencies edit view all mary szelaeducation  university of illinois at chicago administration business  university of illinois at chicago nursing masters of business administration edit mary szelaachievements and recognitions add milestone no milestones has been recorded for mary szela edit mary szelalinks add link no links has been recorded for mary szela mary szelainvestmentsacquisitions no investments has been recorded for mary szela mary szelainvestments representing others no investment reps has been recorded for mary szela mary szelarelated people view all peers  robin bellas partner of lightstone ventures jeanfrançois formela partner of atlas venture fred destin partner of accel partners beth seidenberg partner of kpcb dana mead partner of kpcb robert weigle ceo of benvenue medical view all mary szelarecommended market profiles  telemedicine  or more employees  companies social media marketing chiefmarteccom    employees  companies big data universe list of lists  or more employees  companies aggregated marketing technology  or more employees  companies shared economy landscape jeremiah owyang  or more employees  companies inside sales landscape  or more employees  companies mary t szela sr vp  pharmaceutical operations abbott laboratories a publisher of business information since         search business search executive   advanced search   sign in    hints profile of mary szela   mary szela   sr vp  pharmaceutical operations  abbott laboratories   mary szela email  please login   company name  abbott laboratories   company website  wwwabbottcom   company address   abbott pk rd abbott park ilunited states   mary szela profile  sr vp  pharmaceutical operations  abbott laboratories   mary szela biography  mary szela is senior vice president pharmaceutical operations leading abbott’s commercial pharmaceutical business in the united states she was appointed to this position in august previously she served as vice president commercial pharmaceutical operations where she was responsible for sales and marketing of many of abbotts pharmaceutical brands including humiraszela joined abbott in  and has held several leadership positions at abbott including vice president primary care commercial operations and vice president of hospital business sector responsible for anesthesia acute care cardiovascular and pain management pharmaceuticals in abbotts hospital products business now hospiraprior to joining abbott szela worked for the university of illinois hospitalszela earned a bachelors degree in nursing and a masters degree in business administration from the university of illinois   mary szela colleagues  name title email david owen board dir please login laura schumacher exec vp general counsel sec please login william daley board dir please login john landgraf sr vp  global pharmaceutical manufacturing supply please login richard gonzalez dir pres coo please login             home    about us    product information     subscription    list builder     executive list     email lists     contact us    site map    browse directory        walkerss research  a publisher of business information since  all rights reserved